Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma
In conclusion, circulatory MALAT1 might represent a putative non-invasive prognostic biomarker indicating worse liver failure score in HCV-related HCC patients with traditional markers. Large-scale verification is warranted in future studies.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
More News: Adenocarcinoma | Bilirubin | Cancer | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Hepatocellular Carcinoma | Liver | Liver Cancer | Study | Urology & Nephrology